EyePoint Pharmaceuticals, Inc. (EYPT)

NASDAQ: EYPT · IEX Real-Time Price · USD

8.80

-0.05 (-0.56%)

At close: Jul 19, 2024, 4:00 PM

8.88

+0.08 (0.91%)

Pre-market: Jul 20, 2024, 9:29 AM EDT

EyePoint Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2002
Revenue	50.02	46.02	41.4	36.94	34.44	20.37	Upgrade
Revenue Growth (YoY)	25.70%	11.14%	12.09%	7.27%	69.10%	587.77%	Upgrade
Cost of Revenue	4.75	4.63	8.33	8.18	5.82	2.69	Upgrade
Gross Profit	45.27	41.39	33.08	28.76	28.61	17.68	Upgrade
Selling, General & Admin	50.92	51.79	60.32	53.08	46.02	47.71	Upgrade
Research & Development	81.18	64.66	49.64	28.5	17.42	15.37	Upgrade
Other Operating Expenses	0	0	22.75	2.46	2.46	2.46	Upgrade
Operating Expenses	132.1	116.45	132.72	84.04	65.9	65.54	Upgrade
Operating Income	-86.83	-75.07	-99.64	-55.28	-37.29	-47.86	Upgrade
Interest Expense / Income	0.44	1.25	3.19	5.5	7.26	6.18	Upgrade
Other Expense / Income	-8.44	-5.6	-0.57	-2.36	0.85	2.76	Upgrade
Pretax Income	-78.83	-70.71	-102.25	-58.42	-45.39	-56.79	Upgrade
Income Tax	0.08	0.08	0	0	0	0	Upgrade
Net Income	-78.92	-70.8	-102.25	-58.42	-45.39	-56.79	Upgrade
Shares Outstanding (Basic)	53	39	37	29	13	10	Upgrade
Shares Outstanding (Diluted)	53	39	37	29	13	10	Upgrade
Shares Change	41.15%	4.25%	29.76%	124.04%	23.06%	125.65%	Upgrade
EPS (Basic)	-1.81	-1.82	-2.74	-2.03	-3.54	-5.44	Upgrade
EPS (Diluted)	-1.81	-1.82	-2.74	-2.03	-3.54	-5.44	Upgrade
Free Cash Flow	-16.65	-1.61	-67.16	-50.25	-14.8	-56.91	Upgrade
Free Cash Flow Per Share	-0.32	-0.04	-1.80	-1.75	-1.15	-5.46	Upgrade
Gross Margin	90.50%	89.93%	79.89%	77.86%	83.09%	86.81%	Upgrade
Operating Margin	-173.60%	-163.13%	-240.65%	-149.64%	-108.28%	-235.02%	Upgrade
Profit Margin	-157.77%	-153.84%	-246.97%	-158.14%	-131.82%	-278.88%	Upgrade
Free Cash Flow Margin	-33.30%	-3.49%	-162.19%	-136.04%	-42.97%	-279.46%	Upgrade
EBITDA	-77.74	-69	-96.62	-50.15	-35.49	-48.01	Upgrade
EBITDA Margin	-155.41%	-149.94%	-233.36%	-135.76%	-103.05%	-235.76%	Upgrade
Depreciation & Amortization	0.66	0.46	2.45	2.77	2.65	2.6	Upgrade
EBIT	-78.4	-69.47	-99.07	-52.92	-38.14	-50.62	Upgrade
EBIT Margin	-156.73%	-150.95%	-239.26%	-143.26%	-110.74%	-248.55%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).